Tandem Diabetes Care, Inc.
A maker of insulin pumps and automated insulin delivery systems for people with type 1 and type 2 diabetes. Its t:slim X2 and Tandem Mobi pumps, powered by the Control-IQ+ algorithm, work with continuous glucose monitors to help predict and prevent high and low blood sugar events. The company serves nearly 500,000 people across more than 25 countries.
Estimated from filings — the split-adjusted price range over the quarters each manager built the position. A range, not a fill price; 13F reports a quarter-end snapshot, not a trade date.